These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26861645)

  • 1. Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications.
    Facciorusso A; Villani R; Bellanti F; Mitarotonda D; Vendemiale G; Serviddio G
    Curr Pharm Des; 2016; 22(18):2689-96. PubMed ID: 26861645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
    Liu B; Jin J; Zhang Z; Zuo L; Jiang M; Xie C
    Biochem Cell Biol; 2019 Aug; 97(4):397-405. PubMed ID: 30475643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells.
    Zhang X; Kang Y; Huo T; Tao R; Wang X; Li Z; Guo Q; Zhao L
    Free Radic Biol Med; 2017 Nov; 112():49-59. PubMed ID: 28697922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel benzotriazole derivative inhibits proliferation of human hepatocarcinoma cells by increasing oxidative stress concomitant mitochondrial damage.
    Zhang SS; Zhang HQ; Li D; Sun LH; Ma CP; Wang W; Wan J; Qu B
    Eur J Pharmacol; 2008 Apr; 584(1):144-52. PubMed ID: 18343364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Signalling Pathways in Hepatocellular Carcinoma.
    Blagotinsek K; Rozman D
    Curr Pharm Des; 2017; 23(1):170-175. PubMed ID: 27719638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cordycepin Affects Multiple Apoptotic Pathways to Mediate Hepatocellular Carcinoma Cell Death.
    Zhou Y; Guo Z; Meng Q; Lu J; Wang N; Liu H; Liang Q; Quan Y; Wang D; Xie J
    Anticancer Agents Med Chem; 2017; 17(1):143-149. PubMed ID: 27225448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
    Sun Y; Xu H; Chen X; Li X; Luo B
    Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mito-TEMPO, a mitochondria-targeted antioxidant, prevents N-nitrosodiethylamine-induced hepatocarcinogenesis in mice.
    Shetty S; Kumar R; Bharati S
    Free Radic Biol Med; 2019 May; 136():76-86. PubMed ID: 30946961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indazolo[3,2-b]quinazolinones Attack Hepatocellular Carcinoma Hep3B Cells by Inducing Mitochondrial-Dependent Apoptosis and Inhibition of Nrf2/ARE Signaling Pathway.
    Zhang Y; Qiao R; He D; Zhao Z; Yang S; Zou H; Zhang X; Wu M; Chen J; Chen P
    Curr Mol Med; 2016; 16(9):820-828. PubMed ID: 27894242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives.
    Giovannini C; Bolondi L; Gramantieri L
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases.
    Wu YT; Wu SB; Wei YH
    Curr Pharm Des; 2014; 20(35):5510-26. PubMed ID: 24606797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway.
    Ma T; Fan BY; Zhang C; Zhao HJ; Han C; Gao CY; Luo JG; Kong LY
    Sci Rep; 2016 Jul; 6():29926. PubMed ID: 27416811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal metabolite compound K of ginseng saponin potently attenuates metastatic growth of hepatocellular carcinoma by augmenting apoptosis via a Bid-mediated mitochondrial pathway.
    Song G; Guo S; Wang W; Hu C; Mao Y; Zhang B; Zhang H; Hu T
    J Agric Food Chem; 2010 Dec; 58(24):12753-60. PubMed ID: 21121651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
    Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
    Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel resveratrol derivative 3,5-diethoxy-3',4'-dihydroxy-trans-stilbene induces mitochondrial ROS-mediated ER stress and cell death in human hepatoma cells in vitro.
    Park JW; Choi WG; Lee PJ; Chung SW; Kim BS; Chung HT; Cho S; Kim JH; Kang BH; Kim H; Kim HP; Back SH
    Acta Pharmacol Sin; 2017 Nov; 38(11):1486-1500. PubMed ID: 28795692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
    García-Vilas JA; Medina MÁ
    World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage.
    Tan J; Song M; Zhou M; Hu Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):17-23. PubMed ID: 28069382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells.
    Dogan Turacli I; Candar T; Yuksel BE; Demirtas S
    Hum Exp Toxicol; 2018 Sep; 37(9):909-919. PubMed ID: 29185360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult.
    Yeh TC; Chiang PC; Li TK; Hsu JL; Lin CJ; Wang SW; Peng CY; Guh JH
    Biochem Pharmacol; 2007 Mar; 73(6):782-92. PubMed ID: 17188247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.